KBC Equity Fund Pharma C
| MVD-Fonds Rating | EDA |
|---|---|
  | - |
ISIN: BE0166584350 | WKN: 633868
KAG: KBC AM NV
NAV: 2.399,06 EUR am 01.12.2021
Portfolio
Watchlist
KursalarmChart
Kennzahlen KBC Equity Fund Pharma C
| 1M | 6M | 1J | 3J | 5J | 10J | Beginn | |
| Performance | -1,48% | +19,07% | +29,37% | +49,95% | +81,73% | +295,73% | +383,89% |
| Volatilität | +11,24% | +11,12% | +11,00% | +18,11% | +16,02% | +15,28% | +17,09% |
| Sharpe Ratio | -1,47 | +3,79 | +2,72 | +0,83 | +0,83 | +1,00 | +0,44 |
| Bester Monat | - | +6,64% | +6,64% | +11,33% | +11,33% | +11,33% | +11,33% |
| Schl. Monat | - | -2,72% | -2,72% | -10,35% | -10,35% | -10,35% | -12,15% |
| Max. Verlust | -3,60% | -5,36% | -6,19% | -28,06% | -28,06% | -28,06% | -60,14% |
Monatsperformance KBC Equity Fund Pharma C
| 2021 | 2020 | 2019 | 2018 | 2017 | |
| Januar | +4,17% | -0,50% | +9,54% | +2,43% | -0,22% |
| Februar | -2,42% | -5,95% | +2,97% | -3,63% | +7,71% |
| März | +5,48% | -4,31% | +2,65% | -2,87% | +0,32% |
| April | +2,03% | +11,33% | -1,85% | +3,25% | +0,24% |
| Mai | +1,13% | +2,14% | -1,57% | +5,59% | -2,60% |
| Juni | +6,64% | -1,47% | +4,11% | +1,50% | +1,10% |
| Juli | +4,04% | -1,69% | +1,48% | +6,18% | -3,72% |
| August | +3,23% | +0,96% | +0,70% | +3,78% | -0,45% |
| September | -2,72% | +0,46% | -0,38% | +0,80% | +1,37% |
| Oktober | +6,34% | -4,84% | +1,97% | -4,82% | -1,95% |
| November | -0,29% | +5,54% | +6,02% | +3,56% | -0,76% |
| Dezember | -0,74% | -0,41% | +1,46% | -10,35% | -0,35% |
| Gesamt | +29,73% | +0,06% | +30,04% | +4,14% | +0,26% |
Diese Fonds könnten Sie auch interessieren
Vergleichen Sie diese Fonds mit Ihrem ausgewähltem Fonds (KBC Equity Fund Pharma) oder suchen Sie weitere Top-Fonds zum Thema Aktien (Branche Gesundheit/Pharma) weltweit in EUR:
Fonds vergleichenWeitere ähnliche Fonds